- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 01.12. | Marpai meldet starke Vertriebserfolge für 2026 und verlängert Vereinbarung mit Aetna | 12 | Investing.com Deutsch | ||
| 01.12. | Marpai reports strong 2026 sales and renews Aetna network agreement | 6 | Investing.com | ||
| 13.11. | Marpai verfehlt Gewinnerwartungen - Aktie bricht um 20 % ein | 2 | Investing.com Deutsch | ||
| 13.11. | Marpai GAAP EPS of -$0.20, revenue of $4.03M | 1 | Seeking Alpha | ||
| 12.11. | Marpai Reports Third Quarter 2025 Financial Results | 76 | PR Newswire | Continued Turnaround Driven by Cost Discipline and Operational Efficiency; Positioned for Strong 2026 Growth
TAMPA, Fla., Nov. 12, 2025 /PRNewswire/ -- Marpai... ► Artikel lesen | |
| 12.11. | Marpai, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| MARPAI Aktie jetzt für 0€ handeln | |||||
| 12.11. | Marpai, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 06.10. | Marpai receives $200,000 investment from CEO's investment fund | 1 | Investing.com | ||
| 06.10. | Marpai raises $200K in private placement with CEO-backed HillCour Investment | 1 | Seeking Alpha | ||
| 06.10. | Marpai, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 16.09. | Marpai, Inc. - 8-K, Current Report | 3 | SEC Filings | ||
| 29.08. | Führungswechsel bei Marpai: Dallas Scrip wird neuer Präsident nach Rücktritt von John Powers | 1 | Investing.com Deutsch | ||
| 27.08. | Marpai, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 13.08. | Marpai GAAP EPS of -$0.28, revenue of $4.6M | 1 | Seeking Alpha | ||
| 13.08. | Marpai, Inc. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
| 13.08. | Marpai Reports Second Quarter 2025 Financial Results | 361 | PR Newswire | Marpai Slashes Losses by Two-Thirds in Q2 2025, Paving the Way to Profitability.Operating Expenses Cut 70% as Turnaround Gains Traction
TAMPA, Fla., Aug. 13,... ► Artikel lesen | |
| 04.08. | Marpai, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 21.07. | Marpai, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 14.05. | Marpai Reports First Quarter 2025 Financial Results | 133 | PR Newswire | Marpai's turnaround momentum is building
TAMPA, Fla., May 14, 2025 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX: MRAI), a leader in innovative... ► Artikel lesen | |
| 13.05. | Marpai Hires Dallas Scrip As Chief Operating Officer | 146 | PR Newswire | Marpai Bolsters Leadership Team to Drive Profitable High-Growth Strategy with Key Executive Appointment
TAMPA, Fla., May 13, 2025 /PRNewswire/ -- Marpai, Inc.... ► Artikel lesen |
1 2 Weiter >>
22 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 48,760 | +0,43 % | AT&S: Neuer Vorstand mit Fresenius-Erfahrung | Der Aufsichtsrat von AT&S beruft ein neues Vorstandsmitglied. Gerrit Steen wird den Vorstand der Gesellschaft zum 1. Februar 2026 verstärken. Der wird dann den Posten des CFO übernehmen. Steen war zuletzt... ► Artikel lesen | |
| TELADOC HEALTH | 6,056 | -2,07 % | HIMS vs. TDOC: Which Telehealth Stock Looks More Compelling? | ||
| NUGEN MEDICAL DEVICES | 0,016 | -11,11 % | NuGen Medical: Kurs explodiert nach wichtiger News! | ||
| ATOSSA THERAPEUTICS | 0,600 | -0,83 % | Atossa Therapeutics Inc: Atossa Therapeutics Receives FDA Rare Pediatric Disease Designation for (Z)-Endoxifen for Duchenne Muscular Dystrophy | Designation expands (Z)-Endoxifen program into rare pediatric neuromuscular disease and may qualify Atossa for a future Priority Review Voucher upon approval
SEATTLE... ► Artikel lesen | |
| CO-DIAGNOSTICS | 0,198 | -2,94 % | Co-Diagnostics Reports Third Quarter 2025 Financial Results | SALT LAKE CITY, Nov. 13, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX) ("Co-Diagnostics," "Co-Dx," or "the Company"), a molecular diagnostics company... ► Artikel lesen | |
| LOGICMARK | - | - | LogicMark, Inc. Announces Third Quarter 2025 Results | LOUISVILLE, Ky., Nov. 12, 2025 (GLOBE NEWSWIRE) -- LogicMark, Inc.?(OTC: LGMKD) (the Company), a provider of personal safety and emergency response systems (PERS), health communications devices, and... ► Artikel lesen | |
| ASSURANCE HEALTHCARE | 0,001 | 0,00 % | ASSURANCE HEALTHCARE LIMITED: FINANCIAL STATEMENTS AND RELATED ANNOUNCEMENT::HALF YEARLY RESULTS | ||
| INVO FERTILITY | 0,838 | -4,16 % | INVO Fertility, Inc.: INVO Fertility Signs Definitive Purchase Agreement to Acquire Indiana-Based Fertility Clinic "Family Beginnings" | SARASOTA, Fla. and INDIANAPOLIS, Dec. 17, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) ("INVO" or the "Company"), a healthcare fertility company focused on the establishment, acquisition... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 18,780 | -1,93 % | Alignment Healthcare, Inc. - S-8, Securities to be offered to employees in employee benefit plans | ||
| BRIGHTSPRING HEALTH SERVICES | 37,750 | +0,05 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P SmallCap 600 | NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective... ► Artikel lesen | |
| NATERA | 233,64 | -0,81 % | Natera, Inc.: Natera and MEDSIR to Collaborate on the MiRaDoR Trial in Breast Cancer | Multicenter, Signatera Genome-guided interventional trial will evaluate different treatment approaches in HR+/HER2- breast cancer Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA... ► Artikel lesen | |
| PROGYNY | 25,800 | +1,14 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 32,410 | -1,43 % | Promising Growth Forecasts Leading to Analysts' Optimism for Procept Biorobotics (PRCT) | ||
| LIFESTANCE HEALTH GROUP | 7,130 | +0,56 % | LifeStance Health Group, Inc.: LifeStance Reports Third Quarter 2025 Results | SCOTTSDALE, Ariz., Nov. 06, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| HEARTFLOW | 29,830 | -2,00 % | Heartflow, Inc.: Heartflow FFRCT Analysis Delivers Prognostic Power and Significant Cost Savings in New Analyses of Over 90,000 Patients with Coronary Artery Disease | Lesion-specific FFRCT predicts individual cardiovascular outcomes and delivers greater-than-modeled cost savings for real-world population in FISH&CHIPS analyses from England's National Health ServiceMOUNTAIN... ► Artikel lesen |
MARPAI INC gehört der Branche Gesundheitswesen an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu MARPAI INC finden Sie auf Wallstreet Online.